AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
156 hedge funds and large institutions have $703M invested in Aerie Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 52 funds opening new positions, 47 increasing their positions, 45 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
4% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 45
Holders
156
Holding in Top 10
3
Calls
$610K
Puts
$454K
Top Buyers
| 1 | +$31.5M | |
| 2 | +$24M | |
| 3 | +$16.3M | |
| 4 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$15.6M |
| 5 |
Goldman Sachs
New York
|
+$11.9M |
Top Sellers
| 1 | -$23M | |
| 2 | -$19.7M | |
| 3 | -$14.9M | |
| 4 |
Morgan Stanley
New York
|
-$10.2M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$9.24M |
